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To the Editor: Dengue is the most prevalent arthro-
pod-borne viral disease in tropical and subtropical coun-
tries. Every year, dengue virus (DENV) infections cause 
more than 50 million cases, 500,000 hospitalizations, and 
12,500 deaths worldwide (1). DENV belongs to the ge-
nus Flavivirus and is transmitted by Aedes spp. mosqui-
toes. There are 4 distinct serotypes (DENV-1 to DENV-4), 
and infection with 1 serotype does not provide long-term, 
cross-protective immunity against the other 3 serotypes.
In New Caledonia, DENV outbreaks have occurred 
since World War II and have been caused mainly by 1 se-
rotype/genotype introduced from a country to which den-
gue is hyperendemic. Since 2000, New Caledonia has had 
recurrent DENV-1 outbreaks (2). In 2014, circulation of 
DENV-1 and DENV-3 was still reported in this country (3).
Zika virus (ZIKV) is an emerging mosquito-borne vi-
rus that belongs to the genus Flavivirus and was first iso-
lated in Uganda (4). ZIKV is believed to be transmitted to 
humans by Aedes spp. mosquitoes. Before 2007, few hu-
man cases of infection had been reported. In 2007, the first 
Zika epidemic occurred in Yap, Federated States of Micro-
nesia (5). In October 2013, a ZIKV outbreak was reported 
in French Polynesia (6).
In New Caledonia, the first cases of ZIKV infection 
imported from French Polynesia were confirmed at the end 
of November 2013, and the first autochthonous cases were 
reported by mid-January 2014. Early in February 2014, 
the New Caledonia Health Authority declared an outbreak 
situation. Since February 2014, a total of 1,385 ZIKV lab-
oratory-confirmed cases have been detected, including 35 
imported cases (32 from French Polynesia, 2 from Vanuatu, 
and 1 from the Cook Islands). Concomitant with this ZIKV 
outbreak, circulation of DENV-1 and DENV-3 was report-
ed; >150 cases were biologically confirmed during Janu-
ary–September 2014 (3). Thus, New Caledonia currently 
has 3 arboviruses co-circulating.
In recent years, co-circulation of multiple DENV 
serotypes or DENV and chikungunya virus has been re-
ported. Although rare co-infections have been identified 
(7,8), given the similar clinical features and lack of con-
current testing, co-infections might not be identified. We 
report detection of ZIKV and DENV genomes in serum of 
a traveler (patient 1) who returned from French Polynesia 
where ZIKV and DENV were co-circulating (6,9) and in 
serum of a person (patient 2) in New Caledonia who had no 
travel history. The traveler was co-infected with ZIKV and 
DENV-3, and the local patient was co-infected with ZIKV 
and DENV-1.
Patient 1 was a 14-year-old boy who had fever 
(39.5°C), headache, arthralgia, asthenia, and myalgia. No 
hemorrhagic or neurologic findings were reported, and the 
patient recovered within 3 days. A complete blood count 
showed mild thrombocytopenia (platelet count 129 × 109 
platelets/L; reference range 150–400 × 109 platelets/L), 
leukopenia (leukocyte count 2.75 × 109 cells/L; reference 
range 4–10 × 109 cells/L) with associated stimulated lym-
phocytes, and discreet hepatic cytolysis (aspartate amino-
transferase 55 IU/L; reference value <34 UI/L, and alanine 
aminotransferase 51 IU/L; reference value <55 IU/L). Se-
rum was analyzed by using real-time reverse transcription 
PCR (RT-PCR) and was positive for ZIKV as recommend-
ed by Lanciotti et al. (5) and DENV-3.
Patient 2 was a 38-year-old woman who had fever 
(40°C), headache, arthralgia, asthenia, myalgia, retroor-
bital pain, conjunctivitis, diarrhea, nausea, and a diffuse 
pruritic maculopapular rash. No hemorrhagic or neurologic 
findings were reported, but signs of illness lasted ≈1 week. 
The patient had mild thrombocytopenia (platelet count 123 
× 109 platelets/L) and leukopenia (leukocyte count 2.65 × 
109 cells/L). Serum was analyzed by using RT-PCR (5) and 
was positive for ZIKV and DENV-1.
Co-infections were assessed by sequencing partial 
ZIKV membrane–envelope gene regions for isolates (Gen-
Bank accession nos. KM212963 and KM212967) from 
both patients, partial DENV-1 envelope gene for an isolate 
(KM212960) from patient 2, and partial DENV-3 nonstruc-
tural protein 5 gene for an isolate (KM212962) from patient 
1. Sequencing was conducted at La Plateforme du Vivant 
(Noumea, New Caledonia).
DENV-1 sequence obtained belonged to genotype 
I and clustered with DENV-1 sequences isolated in New 
Caledonia (2). DENV-3 sequence obtained  belonged to 
genotype III, similar to DENV-3 recently isolated in French 
Polynesia (9). ZIKV sequences obtained belonged to the 
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Asian lineage and had 99% identity with sequences of 
ZIKV isolated in French Polynesia in 2013 (10).
Serum specimens from both patients were cultured on 
Vero cells, and supernatants were evaluated by RT-PCR. 
Each specimen was positive only for DENV, which was 
probably caused by low viral loads for ZIKV.
We report co-infection of 2 patients with DENV and 
ZIKV; each patient was infected with a different DENV se-
rotype. No synergistic effects of the 2 viral infections were 
observed because both patients were not hospitalized and 
recovered after a mild clinical course.
During this outbreak, patients in New Caledonia were 
tested for DENV, chikungunya virus, and ZIKV within the 
framework of the arboviruses sentinel network, which en-
abled detection of co-infections. Thus, clinicians should 
be aware of infections with multiple pathogens in the dif-
ferential diagnosis of dengue-like illness, especially in pa-
tients who returned from tropical regions. This diagnostic 
procedure could be improved by using multiplex RT-PCR 
for travelers, given the frequent co-circulation of multiple 
arboviruses in tropical regions.
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To the Editor: Primary amebic meningoencephali-
tis (PAM) is an acute and fulminant disease caused by 
Naegleria fowleri, an amphizoic ameba belonging to the 
family Vahlkampfidae. About 235 PAM cases have been 
described worldwide, most in children and immunocom-
petent young adults (1,2). The infection occurs through 
the nose; the ameba enters through the nasal passages and 
ascends the olfactory nerve until it reaches the olfactory 
bulb of the central nervous system. The incubation period 
for PAM ranges from 5 to 7 days, and infection leads to 
death within a week. Symptom onset is abrupt, with bi-
frontal or bitemporal headaches, fever, and stiff neck, fol-
lowed by nausea, vomiting, irritability, and fatigue. The 
mortality rate is as high as 95%; few cases of survival 
have been reported (2,3). 
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